• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $EMIS

    Emmis Acquisition Corp.

    Subscribe to $EMIS
    $EMIS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    IPO Year: 2025

    Exchange: NASDAQ

    Recent Analyst Ratings for Emmis Acquisition Corp.

    DatePrice TargetRatingAnalyst
    See more ratings

    Emmis Acquisition Corp. Press Releases

    Fastest customizable press release news feed in the world

    View All

    Sichenzia Ross Ference Carmel LLP Achieves Firm Record Advising on Over 170 Transactions Totaling Over $14 Billion in 2025

    NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Sichenzia Ross Ference Carmel LLP ("SRFC") reported that in 2025 it advised on over 170 announced transactions, with the total value of these transactions exceeding $14 billion, far surpassing the firm's strong performance in 2024. The transactions, on behalf of various market participants, such as issuers, underwriters and investors, included initial public offerings, secondary public offerings, registered direct offerings, private placements, mergers, acquisitions and cryptocurrency transactions. In October of 2025, for the fifth consecutive quarter, SRFC was ranked first in the nation for issuer counsel among securities law firms in Placement

    1/20/26 8:00:00 AM ET
    $EMIS
    $NCRA
    $SOUL
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Farming/Seeds/Milling
    Consumer Staples

    Emmis Acquisition Corp. SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Emmis Acquisition Corp.

    SCHEDULE 13G - Emmis Acquisition Corp. (0002075816) (Subject)

    11/13/25 4:37:06 PM ET
    $EMIS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-Q filed by Emmis Acquisition Corp.

    10-Q - Emmis Acquisition Corp. (0002075816) (Filer)

    11/13/25 4:18:27 PM ET
    $EMIS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SCHEDULE 13G filed by Emmis Acquisition Corp.

    SCHEDULE 13G - Emmis Acquisition Corp. (0002075816) (Subject)

    11/13/25 9:59:43 AM ET
    $EMIS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SCHEDULE 13G filed by Emmis Acquisition Corp.

    SCHEDULE 13G - Emmis Acquisition Corp. (0002075816) (Subject)

    11/13/25 9:05:24 AM ET
    $EMIS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-Q filed by Emmis Acquisition Corp.

    10-Q - Emmis Acquisition Corp. (0002075816) (Filer)

    11/4/25 4:37:04 PM ET
    $EMIS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Emmis Acquisition Corp. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Mallon-De Castro Anna Christin

    3 - Emmis Acquisition Corp. (0002075816) (Issuer)

    11/12/25 8:50:47 AM ET
    $EMIS
    Biotechnology: Pharmaceutical Preparations
    Health Care